Lithium encephalopathy: a clinical, psychiatric, and EEG evaluation

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Toxicology

Background:

• Lithium is a widely used mood stabilizer in psychiatric treatment.
• Neuroleptic medications are frequently prescribed for various mental health conditions.
• The potential for drug-induced organic brain syndromes necessitates careful patient monitoring.

Observation:

• Three cases are presented where lithium, in conjunction with a neuroleptic, was suspected of inducing organic brain syndrome.
• Patients exhibited clinical symptoms and electroencephalogram (EEG) abnormalities consistent with organic brain syndrome.
• The specific combination of lithium and neuroleptic therapy was the focus of clinical concern.

Findings:

• Withdrawal of lithium therapy led to the reversal of clinical symptoms in affected patients.
• EEG abnormalities normalized following the discontinuation of lithium.
• These findings suggest a direct causal link between lithium-neuroleptic combination and the observed organic brain syndrome.

Implications:

• This study highlights the importance of considering drug-induced causes for organic brain syndromes.
• Clinicians should exercise caution when prescribing lithium concurrently with neuroleptic medications.
• Further research is warranted to elucidate the precise mechanisms and prevalence of this adverse drug reaction.